Resolute Capital Asset Partners LLC Viking Therapeutics, Inc. Transaction History
Resolute Capital Asset Partners LLC
- $192 Million
- Q3 2024
A detailed history of Resolute Capital Asset Partners LLC transactions in Viking Therapeutics, Inc. stock. As of the latest transaction made, Resolute Capital Asset Partners LLC holds 50,000 shares of VKTX stock, worth $1.7 Million. This represents 1.65% of its overall portfolio holdings.
Number of Shares
50,000Holding current value
$1.7 Million% of portfolio
1.65%Shares
2 transactions
Others Institutions Holding VKTX
# of Institutions
469Shares Held
63.2MCall Options Held
5.76MPut Options Held
3.39M-
Vanguard Group Inc Valley Forge, PA10.2MShares$346 Million0.01% of portfolio
-
Black Rock Inc. New York, NY6.03MShares$205 Million0.01% of portfolio
-
State Street Corp Boston, MA4.67MShares$159 Million0.01% of portfolio
-
Jpmorgan Chase & CO New York, NY2.12MShares$72.1 Million0.01% of portfolio
-
Morgan Stanley New York, NY1.87MShares$63.8 Million0.01% of portfolio
About Viking Therapeutics, Inc.
- Ticker VKTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 76,688,496
- Market Cap $2.61B
- Description
- Viking Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of novel therapies for metabolic and endocrine disorders. The company's lead drug candidate is VK2809, an orally available tissue and receptor-subtype selective agonist of the thyroid hormone receptor beta (TRß), which is in Phase IIb clinical trial...